SINEMET CR levodopa/carbidopa 200 mg/50 mg modified release tablet bottle অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

sinemet cr levodopa/carbidopa 200 mg/50 mg modified release tablet bottle

organon pharma pty ltd - carbidopa monohydrate, quantity: 54 mg (equivalent: carbidopa, qty 50 mg); levodopa, quantity: 200 mg - tablet, modified release - excipient ingredients: indigo carmine; hypromellose; hyprolose; allura red ac; magnesium stearate - idiopathic parkinsonism, where standard formulations containing levodopa/carbidopa have produced inadequate control. experience is limited with sinemet cr in patients who have not been treated with levodopa before.

BENZTROP benztropine mesilate 2mg tablet bottle অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

benztrop benztropine mesilate 2mg tablet bottle

phebra pty ltd - benzatropine mesilate, quantity: 2 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; microcrystalline cellulose; magnesium stearate - indicated for the treatment of all forms of parkinsonism. the treatment of extrapyramidal reactions (except tardive dyskinesia [see contraindications and precautions]) due to neuroleptic drugs.

APOWOK apomorphine hydrochloride hemihydrate 10 mg/mL solution for injection or infusion ampoule অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apowok apomorphine hydrochloride hemihydrate 10 mg/ml solution for injection or infusion ampoule

wockhardt bio pty ltd - apomorphine hydrochloride hemihydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium hydroxide; hydrochloric acid; water for injections - apowok solution for injection or infusion is indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.

APO-LEVODOPA/CARBIDOPA 100/25 levodopa 100 mg and carbidopa (as monohydrate) 25 mg tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apo-levodopa/carbidopa 100/25 levodopa 100 mg and carbidopa (as monohydrate) 25 mg tablet blister pack

arrotex pharmaceuticals pty ltd - carbidopa monohydrate, quantity: 27 mg (equivalent: carbidopa, qty 25 mg); levodopa, quantity: 100 mg - tablet, uncoated - excipient ingredients: crospovidone; quinoline yellow aluminium lake; microcrystalline cellulose; magnesium stearate; pregelatinised maize starch - apo-levodopa/carbidopa is indicated for the treatment of parkinson's disease and syndrome. it is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. apo-levodopa/carbidopa frequently is helpful in the management of tremor, dysphagia, sialorrhoea and postural instability associated with parkinson's disease and syndrome.

APO-LEVODOPA/CARBIDOPA 250/25 levodopa 250 mg and carbidopa (as monohydrate) 25 mg tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apo-levodopa/carbidopa 250/25 levodopa 250 mg and carbidopa (as monohydrate) 25 mg tablet blister pack

arrotex pharmaceuticals pty ltd - levodopa, quantity: 250 mg; carbidopa monohydrate, quantity: 27 mg (equivalent: carbidopa, qty 25 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; crospovidone; pregelatinised maize starch; indigo carmine aluminium lake - apo-levodopa/carbidopa is indicated for the treatment of parkinson's disease and syndrome. it is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. apo-levodopa/carbidopa frequently is helpful in the management of tremor, dysphagia, sialorrhoea and postural instability associated with parkinson's disease and syndrome.

SINADOPA 250/25 levodopa 250 mg and carbidopa (as monohydrate) 25 mg tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

sinadopa 250/25 levodopa 250 mg and carbidopa (as monohydrate) 25 mg tablet blister pack

arrotex pharmaceuticals pty ltd - levodopa, quantity: 250 mg; carbidopa monohydrate, quantity: 27 mg (equivalent: carbidopa, qty 25 mg) - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; indigo carmine aluminium lake; crospovidone - sinadopa is indicated for the treatment of parkinson's disease and syndrome. it is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. sinadopa frequently is helpful in the management of tremor, dysphagia, sialorrhoea and postural instability associated with parkinson's disease and syndrome.

SINADOPA 100/25 levodopa 100 mg and carbidopa (as monohydrate) 25 mg tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

sinadopa 100/25 levodopa 100 mg and carbidopa (as monohydrate) 25 mg tablet blister pack

arrotex pharmaceuticals pty ltd - levodopa, quantity: 100 mg; carbidopa monohydrate, quantity: 27 mg (equivalent: carbidopa, qty 25 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; pregelatinised maize starch; quinoline yellow aluminium lake; microcrystalline cellulose; crospovidone - sinadopa is indicated for the treatment of parkinson's disease and syndrome. it is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. sinadopa frequently is helpful in the management of tremor, dysphagia, sialorrhoea and postural instability associated with parkinson's disease and syndrome.

SINEMET 250/25 levodopa/carbidopa 250 mg/25 mg tablet bottle অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

sinemet 250/25 levodopa/carbidopa 250 mg/25 mg tablet bottle

organon pharma pty ltd - carbidopa monohydrate, quantity: 27 mg (equivalent: carbidopa, qty 25 mg); levodopa, quantity: 250 mg - tablet, uncoated - excipient ingredients: indigo blue; maize starch; magnesium stearate; microcrystalline cellulose; pregelatinised maize starch - sinemet is indicated for the treatment of parkinson's disease and syndrome. it is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. sinemet frequently is helpful in the management of tremor, dysphagia, sialorrhoea and postural instability associated with parkinson's disease and syndrome.

SINEMET 100/25 levodopa/carbidopa 100 mg/25 mg tablet bottle অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

sinemet 100/25 levodopa/carbidopa 100 mg/25 mg tablet bottle

organon pharma pty ltd - carbidopa monohydrate, quantity: 27 mg (equivalent: carbidopa, qty 25 mg); levodopa, quantity: 100 mg - tablet, uncoated - excipient ingredients: quinoline yellow; maize starch; pregelatinised maize starch; microcrystalline cellulose; magnesium stearate - sinemet is indicated for the treatment of parkinson's disease and syndrome. it is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. sinemet frequently is helpful in the management of tremor, dysphagia, sialorrhoea and postural instability associated with parkinson's disease and syndrome.

SINEMET CR 200/50 levodopa/carbidopa 200 mg/50 mg modified release tablet bottle অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

sinemet cr 200/50 levodopa/carbidopa 200 mg/50 mg modified release tablet bottle

organon pharma pty ltd - carbidopa monohydrate, quantity: 54 mg (equivalent: carbidopa, qty 50 mg); levodopa, quantity: 200 mg - tablet, modified release - excipient ingredients: hyprolose; magnesium stearate; ferric oxide; va/crotonates copolymer; quinoline yellow aluminium lake - idiopathic parkinsonism, where standard formulations containing levodopa/carbidopa have produced inadequate control. experience is limited with sinemet cr 200/50 in patients who have not been treated with levodopa before.